iRhythm Technologies (IRTC) Projected to Post Quarterly Earnings on Thursday

iRhythm Technologies (NASDAQ:IRTC) will likely be issuing its quarterly earnings data after the market closes on Thursday, February 20th. Analysts expect the company to announce earnings of ($0.29) per share and revenue of $158.30 million for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

iRhythm Technologies Stock Performance

Shares of iRhythm Technologies stock opened at $112.41 on Wednesday. iRhythm Technologies has a one year low of $55.92 and a one year high of $124.11. The company has a market cap of $3.52 billion, a PE ratio of -23.13 and a beta of 1.29. The company has a debt-to-equity ratio of 9.00, a quick ratio of 6.12 and a current ratio of 6.27. The business has a 50-day simple moving average of $99.65 and a 200-day simple moving average of $82.58.

Insider Buying and Selling at iRhythm Technologies

In other iRhythm Technologies news, insider Patrick Michael Murphy sold 2,492 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $85.89, for a total value of $214,037.88. Following the completion of the sale, the insider now owns 35,327 shares in the company, valued at approximately $3,034,236.03. The trade was a 6.59 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.68% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

IRTC has been the subject of a number of analyst reports. Robert W. Baird lowered their price objective on iRhythm Technologies from $100.00 to $79.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Needham & Company LLC upped their price target on iRhythm Technologies from $96.00 to $112.00 and gave the company a “buy” rating in a report on Monday, January 13th. Oppenheimer upped their price target on iRhythm Technologies from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Wednesday, January 8th. Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $86.00 price target on shares of iRhythm Technologies in a report on Tuesday, December 3rd. Finally, Truist Financial upped their price target on iRhythm Technologies from $85.00 to $111.00 and gave the company a “buy” rating in a report on Wednesday, December 18th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, iRhythm Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $108.45.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.